These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29527530)

  • 81. Predictive analysis of ceftazidime hydrolysis in CTX-M-type beta-lactamase family members with a mutational substitution at position 167.
    Kimura S; Ishii Y; Tateda K; Yamaguchi K
    Int J Antimicrob Agents; 2007 Mar; 29(3):326-31. PubMed ID: 17258896
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
    Szabó D; Barcs I; Rozgonyi F
    Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Molecular Basis of Class A β-Lactamase Inhibition by Relebactam.
    Tooke CL; Hinchliffe P; Lang PA; Mulholland AJ; Brem J; Schofield CJ; Spencer J
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383664
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteria.
    Kang CI; Cha MK; Kim SH; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
    Int J Antimicrob Agents; 2014 May; 43(5):456-9. PubMed ID: 24690213
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cefotaxime-hydrolysing beta lactamases in Morganella morganii.
    Power P; Radice M; Barberis C; de Mier C; Mollerach M; Maltagliatti M; Vay C; Famiglietti A; Gutkind G
    Eur J Clin Microbiol Infect Dis; 1999 Oct; 18(10):743-7. PubMed ID: 10584905
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Amino acid sequence requirements at residues 69 and 238 for the SME-1 beta-lactamase to confer resistance to beta-lactam antibiotics.
    Majiduddin FK; Palzkill T
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1062-7. PubMed ID: 12604542
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Comparison of three microbiological methods for detection of expanded-spectrum betalactamases in Enterobacteriaceae isolated in Santa Fe (Argentina)].
    Truppia LA; Mollerach A; Di Conza JA; Radice M; Mugna V; Méndez E; Gutkind GO
    Enferm Infecc Microbiol Clin; 2005 Nov; 23(9):525-8. PubMed ID: 16324563
    [TBL] [Abstract][Full Text] [Related]  

  • 89. QM/MM Simulations Reveal the Determinants of Carbapenemase Activity in Class A β-Lactamases.
    Chudyk EI; Beer M; Limb MAL; Jones CA; Spencer J; van der Kamp MW; Mulholland AJ
    ACS Infect Dis; 2022 Aug; 8(8):1521-1532. PubMed ID: 35877936
    [TBL] [Abstract][Full Text] [Related]  

  • 90. CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia.
    Bradford PA; Yang Y; Sahm D; Grope I; Gardovska D; Storch G
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1980-4. PubMed ID: 9687393
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme.
    Nukaga M; Mayama K; Hujer AM; Bonomo RA; Knox JR
    J Mol Biol; 2003 Apr; 328(1):289-301. PubMed ID: 12684014
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
    Clasen J; Birkegård AC; Græsbøll K; Folkesson A
    J Glob Antimicrob Resist; 2019 Dec; 19():32-39. PubMed ID: 31048029
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ceftazidime-Avibactam Resistance Mutations V240G, D179Y, and D179Y/T243M in KPC-3 β-Lactamase Do Not Alter Cefpodoxime-ETX1317 Susceptibility.
    Shapiro AB; Moussa SH; Carter NM; Gao N; Miller AA
    ACS Infect Dis; 2021 Jan; 7(1):79-87. PubMed ID: 33291867
    [TBL] [Abstract][Full Text] [Related]  

  • 94. An active site loop toggles between conformations to control antibiotic hydrolysis and inhibition potency for CTX-M β-lactamase drug-resistance enzymes.
    Lu S; Hu L; Lin H; Judge A; Rivera P; Palaniappan M; Sankaran B; Wang J; Prasad BVV; Palzkill T
    Nat Commun; 2022 Nov; 13(1):6726. PubMed ID: 36344533
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases.
    Santucci M; Spyrakis F; Cross S; Quotadamo A; Farina D; Tondi D; De Luca F; Docquier JD; Prieto AI; Ibacache C; Blázquez J; Venturelli A; Cruciani G; Costi MP
    Sci Rep; 2017 Dec; 7(1):17716. PubMed ID: 29255163
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Effects on substrate profile by mutational substitutions at positions 164 and 179 of the class A TEM(pUC19) beta-lactamase from Escherichia coli.
    Vakulenko SB; Taibi-Tronche P; Tóth M; Massova I; Lerner SA; Mobashery S
    J Biol Chem; 1999 Aug; 274(33):23052-60. PubMed ID: 10438473
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.
    Jarlier V; Nicolas MH; Fournier G; Philippon A
    Rev Infect Dis; 1988; 10(4):867-78. PubMed ID: 3263690
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Klebsiella pneumoniae carbapenemase variant 44 acquires ceftazidime-avibactam resistance by altering the conformation of active-site loops.
    Sun Z; Lin H; Hu L; Neetu N; Sankaran B; Wang J; Prasad BVV; Palzkill T
    J Biol Chem; 2024 Jan; 300(1):105493. PubMed ID: 38000656
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
    Papp-Wallace KM; Bethel CR; Distler AM; Kasuboski C; Taracila M; Bonomo RA
    Antimicrob Agents Chemother; 2010 Feb; 54(2):890-7. PubMed ID: 20008772
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from U.S. Hospitals.
    Castanheira M; Doyle TB; Mendes RE; Sader HS
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.